Back

Staging and prognostic markers

13 May 2024 (16:12 - 16:24)
Organised by: Logo
Congress Presentation Part of: Cardiac amyloidosis: when translational approaches and personalised medicine become reality Cardiomyopathies HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Daniela Tomasoni

Spedali Civili, University Of Brescia, Brescia (Italy)

3 More presentations in this session

Presentation thumbnail
Pathophysiology and epidemiology
Professor T. Damy (Creteil, FR)
Slides Video
Presentation thumbnail
New therapeutic opportunities: from mechanisms to clinical practice
Professor M. Fontana (London, GB)
Slides Video
Presentation thumbnail
Cardiac amyloidosis: when translational approaches and personalised medicine become reality - discussion
Video

Access the full session

Session thumbnail
Cardiac amyloidosis: when translational approaches and personalised medicine become reality
Video

The Event

Event poster

Heart Failure 2024

13 May 2024 16:12 CET
You may be interested in
thumbnail
Congress Presentation
Staging classification of transthyretin cardiac amyloidosis based on the extent of cardiac damage at echocardiography: a large multicentric Registry.
9 May 2026
thumbnail
Congress Presentation
Hallmarks of early ATTR amyloidosis
22 May 2023
thumbnail
Congress Presentation
Insights on the value of biomarkers in the management of transthyretin amyloid cardiomyopathy (ATTR-CM)
28 August 2023
thumbnail
Congress Presentation
Global longitudinal strain for prognostic staging in wild-type transthyretin cardiac amyloidosis, including under tafamidis treatment
12 December 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources